can you explain the structure of gemtuzumab ozogamicin? where are the linker boundaries?
The trick is probably the disulphide bridge which will be cleaved by reduction, once the construct has been internalized into the target cell, liberating the drug. So I'd consider everything proximal from it towards the antibody as linker structure.